Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,304 across all filing types
Latest filing 2021-02-05 Earnings Release
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Update on KESTREL Phase III trial for Imfinzi
Earnings Release Classification · 99% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement distributed via RNS (Regulatory News Service). The content details the results of a Phase III clinical trial (KESTREL) for a drug (Imfinzi) and includes quotes from an Executive VP and background information on the disease and the drug mechanism. This structure—a formal announcement of clinical trial data/updates, often released via RNS—is characteristic of a general regulatory filing or an announcement that precedes a more detailed report. Since it is not a full Annual Report (10-K), a specific Earnings Release (ER), or a dedicated Investor Presentation (IP), and it is a direct announcement of material information via the RNS system, it fits best under the general 'Regulatory Filings' category, which serves as a fallback for specific announcements not covered elsewhere. It is not a Report Publication Announcement (RPA) because it contains the substantive information itself, not just a notice that a report is available. Q1 2021
2021-02-05 English
FORXIGA APPROVED IN CHINA FOR HEART FAILURE
Foreign Filer Report
2021-02-04 English
Forxiga approved in China for heart failure
Regulatory Filings Classification · 99% confidence The document begins with 'RNS Number : 9846N' and is dated '04 February 2021'. It announces a specific regulatory/medical event: 'Forxiga approved in China for heart failure'. The text is structured as a press release detailing a regulatory approval from China's NMPA and includes quotes from company executives and trial investigators. The presence of the RNS header and the nature of the announcement (a specific, time-sensitive corporate update) strongly indicate this is a general regulatory announcement distributed via the London Stock Exchange's RNS system. Since it is not a full financial report (10-K, IR), a specific management change (MANG), or a dividend notice (DIV), the most appropriate classification is the general regulatory announcement category, RNS.
2021-02-04 English
SEC SCHEDULE 13G
Major Shareholding Notification
2021-02-03 English
TOTAL VOTING RIGHTS
Foreign Filer Report
2021-02-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content details the total number of voting rights and issued share capital as of a specific date (31 January 2021), which is a mandatory disclosure under the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. This type of mandatory, periodic regulatory update that doesn't fit a more specific category (like Director's Dealing or Major Shareholding Notification) is best classified as a general Regulatory Filing or announcement. Given the options, 'Regulatory Filings (RNS)' is the most appropriate general category for an RNS announcement, although it specifically relates to voting rights/capital structure. Since there is no specific code for 'Voting Rights Notification', RNS serves as the best fit for a standard LSE regulatory news service release.
2021-02-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.